Driven by biotech innovation, orphan drug designations, and early diagnostic programs, the mucopolysaccharidosis treatment market is expanding globally with new pipelined therapies and improved patient access. https://www.datamintelligence.com/research-report/mucopolysaccharidosis-treatment-market